Slideshow

Lupus Damage Builds Over Time

Steriod-related damage builds over time for patients with childhood-onset lupus leading to cataracts, avascular necrosis, diabetes and osteoporotic fractures. Learn more in this slideshow.

Disease damage from systemic lupus erythematosus (SLE) is known to predict future mortality, and existing studies suggest childhood-onset lupus could be responsible for increased disease damage than the adult-onset version of the condition. However, little is currently known about adult outcomes of childhood-onset lupus, particularly steroid-related damage. A study published in Seminars in Arthritis & Rheumatism assessed steroid-related damage accumulated over time in adults with childhood-onset and adult-onset disease.This is the first known study to compare damage accrual over time in adults with childhood-onset and adult-onset SLE.In this slideshow, we highlight the findings.Source:  Heshin-Bekenstein M, Trupin L, Yellin E, et al. “Longitudinal Disease- and Steroid-Related Damage Among Adults with Childhood-Onset Systemic Lupus Erythematosus.” Seminars in Arthritis & Rheumatism. June 3, 2019. DOI: 10.1016/j.semarthrit.2019.05.010

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.